+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases



Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases



Netherlands Journal of Medicine 43(1-2): 74-82



Liver transplantation has evolved as the therapy of choice in end-stage liver disease. However, liver transplantation for viral liver disease is associated with recurrence of viral hepatitis in the graft. In this paper we discuss the mechanisms of liver cell damage, the clinical impact of recurrent infection and the use of hepatitis-B-specific immunoglobulin (HBIg) to prevent recurrent infection in the allograft. In addition, we propose an HBIg schedule tailored to each individual patient. Based on the excellent survival results published for acute hepatic failure and chronic liver failure with latent hepatitis B virus (HBV) or hepatitis delta infection, we think that no contraindication exists for liver transplantation in these cases. For patients with active viral replication, liver transplantation should only be considered within a scientific frame to prevent reinfection of the allograft.

(PDF emailed within 1 workday: $29.90)

Accession: 046567543

Download citation: RISBibTeXText

PMID: 8232699


Related references

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. Netherlands Journal of Medicine International Edition 43(1-2): 74-82, 1993

Hepatitis B virus immunoglobulin on demand to prevent infection recurrence among liver allograft recipients: report of three cases. Revista Medica de Chile 140(1): 78-83, 2012

Low-dose hepatitis B immunoglobulin given on demand in combination with lamivudine: A highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. Transplantation (Hagerstown) 77(8): 1203-1208, April 27, 2004

Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clinic Proceedings 64(4): 429-432, 1989

Failure of interferon to prevent recurrent hepatitis b infection in hepatic allograft. Hepatology 8(5): 1287, 1988

Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure. Report of two cases and review of the literature. Journal of Clinical Gastroenterology 17(3): 231-234, 1993

Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review. Journal of Bone Metabolism 21(1): 76-83, 2014

Syphilis and human immunodeficiency virus infection: diagnostic and therapeutic problems. Presentation of 2 cases and review of the literature. Revista Clinica Espanola 188(6): 288-294, 1991

Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review. Clinical Rheumatology 33(4): 577-586, 2015

Hepatic tuberculoma: presentation of cases and review of the literature. Acta Gastroenterologica Latinoamericana 34(1): 21-26, 2004

Hepatic steatosis. Presentation of 89 cases and review of the literature. Acta Clinica Belgica 22(4): 209-226, 1967

Hepatic steatosis Presentation of 89 cases and literature review. 1967

Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis. Current Infectious Disease Reports 18(4): 13-13, 2016

Ambulatory long-term immunoprophylaxis with intramuscular anti-HBs immunoglobulin to prevent hepatitis B reinfection after orthotopic liver transplantation. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A996, April, 2000